Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai Yoshihara

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Endocrine Journal|December 13, 2006
Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapyAi Yoshihara, Osamu Isozaki, Naomi Hizuka, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2014
Identification of a Hashimoto thyroiditis susceptibility locus via a genome-wide comparison with Graves' diseaseDaisuke Oryoji, Sho Ueda, Ken Yamamoto, et al.
Kidney International|November 28, 2021
Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetesCamille Ansermet, Gabriel Centeno, Yohan Bignon, et al.
Endocrine Journal|November 20, 2015
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patientsKoji Mukasa, Jaeduk Yoshimura Noh, Ai Kouzaki, et al.
Endocrine Journal|October 5, 2022
Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid diseaseMarino Hiruma, Natsuko Watanabe, Takako Mitsumatsu, et al.
Thyroid : Official Journal of the American Thyroid Association|August 10, 2013
Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institutionHidemi Ohye, Akinobu Minagawa, Jaeduk Yoshimura Noh, et al.
Clinical Nuclear Medicine|February 26, 2014
Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugsAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Journal of the Endocrine Society|July 2, 2026
Efficacy and safety of propylthiouracil protocols: high-dose monotherapy vs combination of low-dose with iodineNami Suzuki, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Endocrine Journal|January 22, 2025
Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in JapanAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2020
Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of PregnancyAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Endocrine Journal|December 13, 2006
Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapyAi Yoshihara, Osamu Isozaki, Naomi Hizuka, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2014
Identification of a Hashimoto thyroiditis susceptibility locus via a genome-wide comparison with Graves' diseaseDaisuke Oryoji, Sho Ueda, Ken Yamamoto, et al.
Kidney International|November 28, 2021
Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetesCamille Ansermet, Gabriel Centeno, Yohan Bignon, et al.
Endocrine Journal|November 20, 2015
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patientsKoji Mukasa, Jaeduk Yoshimura Noh, Ai Kouzaki, et al.
Endocrine Journal|October 5, 2022
Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid diseaseMarino Hiruma, Natsuko Watanabe, Takako Mitsumatsu, et al.
Thyroid : Official Journal of the American Thyroid Association|August 10, 2013
Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institutionHidemi Ohye, Akinobu Minagawa, Jaeduk Yoshimura Noh, et al.
Clinical Nuclear Medicine|February 26, 2014
Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugsAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Journal of the Endocrine Society|July 2, 2026
Efficacy and safety of propylthiouracil protocols: high-dose monotherapy vs combination of low-dose with iodineNami Suzuki, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Endocrine Journal|January 22, 2025
Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in JapanAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2020
Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of PregnancyAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, et al.
Pageof 7